ReviewRisk of cardiovascular disease associated with exposure to Abacavir (cas 136470-78-5) among individuals with HIV: A systematic review and meta-analyses of results from 17 epidemiologic studies

Add time:09/05/2019    Source:sciencedirect.com

ObjectivesAbacavir (cas 136470-78-5)'s potential to cause cardiovascular disease (CVD) among people living with HIV (PLWH) is debated. We conduct a systematic review and meta-analyses to assess CVD risk from recent and cumulative abacavir exposure.

We also recommend Trading Suppliers and Manufacturers of Abacavir (cas 136470-78-5). Pls Click Website Link as below: cas 136470-78-5 suppliers

Prev:Case reportAbacavir (cas 136470-78-5)-induced liver toxicity
Next:Original articleSwitching from Abacavir (cas 136470-78-5)/lamivudine plus nevirapine to Abacavir (cas 136470-78-5)/lamivudine/dolutegravir in virologically controlled HIV-infected adults (SWAD study)Abacavir (cas 136470-78-5)/lamivudine/dolutégravir après Abacavir (cas 136470-78-5)/lamivudine plus névirapine chez des adultes infectés par le VIH et contrôlés virologiquement (étude SWAD))